The study “Saline Extract From Malpighia emarginata DC Leaves Showed Higher Polyphenol Presence, Antioxidant and Antifungal Activity and Promoted Cell Proliferation in Mice Splenocytes” by Bárbara R. S. Barros et al. (2019) examined whether a saline extract from acerola leaves had measurable biological activity. This summary paraphrases only the scientific paper. The researchers profiled the extract’s chemical composition, tested its antioxidant and antimicrobial activities, and assessed whether it harmed or stimulated mouse splenic immune cells. The paper reports a “higher antioxidant profile,” antifungal activity against several Candida species, “greater cell viability (more than 90%),” and higher splenocyte proliferation after exposure to the extract.

The study explains that Malpighia emarginata is widely known for its fruit, which is rich in vitamin C, carotenoids, anthocyanins, flavonoids, and other bioactive compounds. However, the authors point out that although acerola fruit has been studied extensively, its leaves have received less attention, even though local communities have used them in tea-like preparations. The paper says this matters because the plant's real folk use often relies on water-based preparations rather than organic extracts.

The research question was straightforward. Could a saline leaf extract from acerola show useful biological activity in the lab, especially antioxidant, antifungal, and low-toxicity effects? The paper focused on those points rather than on claims about clinical treatment.

A key part of the scientific paper is the role of plant compounds, including phenolic acids, flavonoids, and other polyphenols. These compounds are often studied because they can interact with unstable molecules linked to oxidative stress. The authors treated acerola leaves as a potential source of those compounds and sought to determine whether the extract’s chemistry matched its biological effects.

The researchers also looked beyond antioxidant action. They tested fungi and bacteria, then examined whether the extract caused cell death in mouse splenocytes. That added an important safety angle to the work. In simple terms, the team was not only asking whether the extract did something useful, but also whether it looked damaging to healthy immune cells under the conditions tested.

The researchers collected acerola leaves in Recife, Brazil, dried them for four days, crushed them, and extracted them in a 0.15 M sodium chloride solution. After filtration and centrifugation, the supernatant was lyophilized, producing 9.2 g of crude material.

They then ran several types of tests:

1. Chemical profiling: total phenols, total flavonoids, and ultra-performance liquid chromatography coupled to mass spectrometry (UPLC-MS).
2. Antioxidant testing: total antioxidant activity (ATT), 2,2-diphenyl-1-picrylhydrazyl (DPPH) free-radical scavenging, and ferric reducing antioxidant power (FRAP).
3. Antimicrobial testing: minimum inhibitory concentration at 50% and 90% growth reduction (MIC50 and MIC90), minimum bactericidal concentration (MBC), minimum fungicidal concentration (MFC), and antibiofilm testing.
4. Cell testing: mouse BALB/c splenocyte viability using Annexin V and propidium iodide, plus proliferation using 5(6)-carboxyfluorescein diacetate N-succinimidyl ester (CFSE).

This was a lab-based study. It was used in in vitro assays and in mouse splenocytes, not in human clinical testing. That makes the findings useful for early scientific understanding, but not a direct guide to human outcomes.

The study found strong evidence of the presence of phenolic compounds in the saline acerola leaf extract. Total phenolic compounds measured 51.14 ± 0.21 mg gallic acid equivalents per gram of extract, and total flavonoids measured 9.67 ± 0.08 mg quercetin equivalents per gram of extract. UPLC-MS identified 18 compounds, including protocatechuic acid, apigenin-7-O-glucoside, apigenin-8-O-glucoside, quinic acid, gallocatechin, salicylic acid, and other compounds from phenolic and terpenoid groups.

This matters because the authors link those compounds to the extract’s subsequent activity in antioxidant and antifungal tests. In short, the chemical profile and the biological results moved in the same direction.

The extract showed measurable antioxidant activity across several assays. The study reports a total antioxidant activity of 20.32 ± 0.89, which the authors describe as about 5 times higher than the butylated hydroxytoluene (BHT) standard value of 4.12 ± 0.10 in that assay. The extract also showed 38.59 ± 1.20% DPPH free-radical sequestration and a ferric ion reduction value of 416.11 ± 0.46 mg EFeSO4(II)/g of extract.

The paper therefore supports the idea that the acerola leaf saline extract exhibited antioxidant activity in the lab, although the exact performance varied across test methods. The authors summarize this overall effect as a “higher antioxidant profile.”

One of the most important findings is that the extract did not show broad antibacterial activity in this study. The paper states that six bacterial species tested showed resistance to the extract. That is a key boundary of the findings.

The stronger signal came from antifungal testing. The extract inhibited Candida albicans, Candida parapsilosis, Candida krusei, and Candida tropicalis, while Candida glabrata was resistant. Reported MIC90 values were 0.52 μg/mL for C. albicans, 0.51 μg/mL for C. parapsilosis, 8.36 μg/mL for C. krusei, and 0.26 μg/mL for C. tropicalis. The study also reports that the extract showed more significant antifungal activity against C. albicans and C. parapsilosis.

The antibiofilm data supported that pattern. The authors report a considerable reduction in biofilm formation for C. albicans, C. krusei, and C. parapsilosis. That suggests the extract may have affected not only fungal growth, but also fungal biofilm behavior for some species.

The cell findings were another major result. Mouse BALB/c splenocytes exposed to the extract at tested concentrations did not show significant cell death by apoptosis or necrosis. The study says the cells showed “greater cell viability (more than 90%).”

The researchers also tested whether the extract affected immune cell proliferation. Using a single concentration of 12.5 μg/mL, they observed higher proliferation indices at 24 and 48 hours. The paper discusses this as a possible sign of immunostimulatory activity and states that the extract promoted a “higher proliferative index” in splenocytes.

The scientific paper suggests that saline acerola leaf extract warrants further study as a natural source of polyphenols with antioxidant and antifungal activities. The authors also emphasize that the extract did not appear toxic to normal mouse splenocytes under the tested conditions, further strengthening the case for additional research.

At the same time, the study does not demonstrate human benefit or broad antibacterial activity. It is better read as an early lab study that points to potential future work on antifungal applications, immune cell responses, and deeper safety testing. The authors conclude that the results support further investigations into the extract as a potential “antifungal and immunostimulant compound in future assays.”

This paraphrased summary of the scientific paper points to a careful conclusion: acerola leaf saline extract appeared chemically rich, exhibited antioxidant activity, performed best against several Candida strains, and did not damage mouse splenocytes in the tested setup. The most responsible reading is that this is an encouraging preclinical study, not a human treatment study, but it gives a solid starting point for future work on antifungal and immune-related properties.